标题
Pleiotropic Effects of Metformin on Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 10, Pages 2850
出版商
MDPI AG
发表日期
2018-09-21
DOI
10.3390/ijms19102850
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin-induced anticancer activities: recent insights
- (2018) Stephen Safe et al. BIOLOGICAL CHEMISTRY
- Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal
- (2018) Muyun Wei et al. BMC CANCER
- Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis
- (2018) Grace H. Tang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus
- (2018) Marie C. Bradley et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid CancerIn VitroandIn Vivo
- (2018) Shilpa Thakur et al. CLINICAL CANCER RESEARCH
- Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis
- (2018) R. Barua et al. CLINICAL ONCOLOGY
- Metformin for non-small cell lung cancer patients: Opportunities and pitfalls
- (2018) Antonin Levy et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Genetic Variants inCPA6andPRPF31Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes
- (2018) Daniel M. Rotroff et al. DIABETES
- Epigenetic effects of metformin: From molecular mechanisms to clinical implications
- (2018) Stephanie Claire Bridgeman et al. DIABETES OBESITY & METABOLISM
- Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells
- (2018) Chenglai Xia et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells
- (2018) Yao Wu et al. EXPERIMENTAL CELL RESEARCH
- Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
- (2018) Sara Pusceddu et al. GASTROENTEROLOGY
- Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway
- (2018) Shuben Sun et al. GENE
- Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings
- (2018) Paola Sena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation
- (2018) Guiju Tang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization
- (2018) Ji-Chang Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression
- (2018) Wen-Shih Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways
- (2018) Yan Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer
- (2018) Aparajita Verma et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells
- (2018) Yan Lv et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes
- (2018) Ruth E Patterson et al. JNCI-Journal of the National Cancer Institute
- Metformin reduces the risk of cancer in patients with type 2 diabetes
- (2018) Hae Jin Kim et al. MEDICINE
- Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus
- (2018) Wen-Xiu Xin et al. MEDICINE
- Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles
- (2018) Vahid Shafiei-Irannejad et al. PHARMACEUTICAL RESEARCH
- Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin
- (2018) Breno C. Landim et al. PROSTATE
- Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes—A Nationwide Cohort Study
- (2018) Yu-Tang Chang et al. Translational Oncology
- Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy
- (2018) Valentina Celestini et al. Cell Death & Disease
- The co‑treatment of metformin with flavone synergistically induces apoptosis through inhibition of PI3K/AKT pathway in breast cancer cells
- (2018) Zhaodi Zheng et al. Oncology Letters
- Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt
- (2018) Zuohong Li et al. Oncology Letters
- Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway
- (2018) Yang Song et al. Oncotarget
- Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells
- (2018) Vineela Chukkapalli et al. Oncotarget
- Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
- (2018) Felipe V. Pereira et al. Oncotarget
- Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
- (2018) Jae Hyun Kim et al. Scientific Reports
- Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects
- (2018) Sara Baldassari et al. Scientific Reports
- High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy
- (2018) Jung Eun Lee et al. Cancer Research and Treatment
- The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes
- (2018) Ruth E Patterson et al. JNCI-Journal of the National Cancer Institute
- Metformin selectively targets redox control of complex I energy transduction
- (2018) Amy R. Cameron et al. Redox Biology
- Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
- (2017) Ruth E Farmer et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
- (2017) Amir Sonnenblick et al. JOURNAL OF CLINICAL ONCOLOGY
- Drug repurposing for the treatment of glioblastoma multiforme
- (2017) Claudia Abbruzzese et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metformin therapy reduces the risk of malignancy after heart transplantation
- (2017) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
- (2017) Shoeb Ikhlas et al. LIFE SCIENCES
- Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients
- (2017) Shujuan Ma et al. MEDICINE
- AMPK: guardian of metabolism and mitochondrial homeostasis
- (2017) Sébastien Herzig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer
- (2017) Matthew D. Thompson et al. Oncology Letters
- Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cells
- (2017) Melissa Hodeib et al. Oncotarget
- The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
- (2017) Yao Xiao et al. Oncotarget
- Metformin and endometrial cancer survival: a quantitative synthesis of observational studies
- (2017) Jianfeng Guo et al. Oncotarget
- Vorinostat and metformin sensitize EGFR-TKI resistant NSCLC cells via BIM-dependent apoptosis induction
- (2017) Hengyi Chen et al. Oncotarget
- Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies
- (2017) Xue-Liang Zhou et al. Oncotarget
- Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
- (2017) Silvia Valtorta et al. Oncotarget
- Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
- (2017) Ying Li et al. Oncotarget
- Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
- (2017) Raana Farajzadeh et al. Artificial Cells Nanomedicine and Biotechnology
- Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
- (2017) Yun-Liang Tang et al. Biomed Research International
- Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state
- (2017) Philipp Schommers et al. Molecular Metabolism
- Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats
- (2017) Ichiro Tokubuchi et al. PLoS One
- Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
- (2017) Maruša Bizjak et al. Scientific Reports
- Results from 11C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration directly
- (2017) Ane B. Iversen et al. Scientific Reports
- The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
- (2017) Xiaogang Li et al. Scientific Reports
- The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells
- (2017) Camille Loubiere et al. Scientific Reports
- Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production
- (2017) Angela Mogavero et al. Scientific Reports
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
- (2016) C. Coyle et al. ANNALS OF ONCOLOGY
- Measuring the biological effect of presurgical metformin treatment in endometrial cancer
- (2016) V N Sivalingam et al. BRITISH JOURNAL OF CANCER
- From obesity to diabetes and cancer: epidemiological links and role of therapies
- (2016) Custodia García-Jiménez et al. BRITISH JOURNAL OF CANCER
- Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
- (2016) Muhammad R. Khawaja et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2
- (2016) Corinna Seliger et al. CELL CYCLE
- Metformin Activates AMPK through the Lysosomal Pathway
- (2016) Chen-Song Zhang et al. Cell Metabolism
- Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy
- (2016) Ryan J.O. Dowling et al. Cell Metabolism
- Mechanism of Metformin: A Tale of Two Sites
- (2016) Ruisheng Song DIABETES CARE
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
- (2016) Pamela T. Soliman et al. GYNECOLOGIC ONCOLOGY
- Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer
- (2016) Christel Häggström et al. INTERNATIONAL JOURNAL OF CANCER
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells
- (2016) Luciano Galdieri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
- (2016) Kaixin Zhou et al. NATURE GENETICS
- Metformin alters DNA methylation genome-wide via the H19/SAHH axis
- (2016) T Zhong et al. ONCOGENE
- Metformin: An anti-diabetic drug to fight cancer
- (2016) Marie Daugan et al. PHARMACOLOGICAL RESEARCH
- Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis
- (2016) Qiuli Liu et al. Oncotarget
- Repurposing metformin for cancer treatment: current clinical studies
- (2016) Young Kwang Chae et al. Oncotarget
- Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC
- (2016) Hongxin Cao et al. Scientific Reports
- New insights into the anti-diabetic actions of metformin: from the liver to the gut
- (2016) Tongzhi Wu et al. Expert Review of Gastroenterology & Hepatology
- Syrosingopine sensitizes cancer cells to killing by metformin
- (2016) Don Benjamin et al. Science Advances
- Repurposing metformin: an old drug with new tricks in its binding pockets
- (2015) R. Pryor et al. BIOCHEMICAL JOURNAL
- Metformin Action: Concentrations Matter
- (2015) Ling He et al. Cell Metabolism
- A Comprehensive Review of Drug–Drug Interactions with Metformin
- (2015) Tore Bjerregaard Stage et al. CLINICAL PHARMACOKINETICS
- The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation. Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
- (2015) John B. Buse et al. DIABETES CARE
- Glucose-deprivation increases thyroid cancer cells sensitivity to metformin
- (2015) Athanasios Bikas et al. ENDOCRINE-RELATED CANCER
- Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome
- (2015) François Cauchy et al. GUT
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1α signaling pathway in ELT-3 cells
- (2015) Mari Tadakawa et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells
- (2015) Nian-Shuang Li et al. TUMOR BIOLOGY
- Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2
- (2015) Wen Yue et al. Oncotarget
- Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
- (2015) Lacey M. Litchfield et al. Oncotarget
- Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
- (2015) Jichang Wang et al. Oncotarget
- Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration
- (2015) Jiaojiao He et al. Scientific Reports
- Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
- (2015) Takla Griss et al. PLOS BIOLOGY
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Biomolecular Mode of Action of Metformin in Relation to Its Copper Binding Properties
- (2014) Peter Repiščák et al. BIOCHEMISTRY
- Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial
- (2014) Akira Mitsuhashi et al. CANCER
- Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
- (2014) Akimasa Takahashi et al. Cancer Cell International
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Type 2 Diabetes: A Protective Factor for Prostate Cancer? An Overview of Proposed Mechanisms
- (2014) Reza Rastmanesh et al. Clinical Genitourinary Cancer
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- Metformin, cancer and glucose metabolism
- (2014) Barbara Salani et al. ENDOCRINE-RELATED CANCER
- Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer
- (2014) Vijayalekshmi Nair et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Convergence of IPMK and LKB1-AMPK Signaling Pathways on Metformin Action
- (2014) Sookhee Bang et al. MOLECULAR ENDOCRINOLOGY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
- (2014) Kıvanç Birsoy et al. NATURE
- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
- (2014) Krzysztof Łabuzek et al. Pharmacological Reports
- Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
- (2014) A. Janzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
- (2014) Y Feng et al. Cell Death & Disease
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
- (2014) Kevin M. Schuler et al. Cancer Medicine
- Glucose promotes breast cancer aggression and reduces metformin efficacy
- (2013) Reema Wahdan-Alaswad et al. CELL CYCLE
- Treatment With Metformin Is Associated With Higher Remission Rate in Diabetic Patients With Thyroid Cancer
- (2013) Joanna Klubo-Gwiezdzinska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes
- (2013) David Margel et al. JOURNAL OF CLINICAL ONCOLOGY
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Repositioning metformin for cancer prevention and treatment
- (2013) Brendan J. Quinn et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
- (2013) Barbara Salani et al. Scientific Reports
- Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Diabetes mellitus and cancer risk: Review of the epidemiological evidence
- (2012) Kentaro Shikata et al. CANCER SCIENCE
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- (2012) Javier A. Menendez et al. CELL CYCLE
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin pathways
- (2012) Li Gong et al. Pharmacogenetics and Genomics
- Distinct perturbation of the translatome by the antidiabetic drug metformin
- (2012) O. Larsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
- (2012) Arian Emami Riedmaier et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
- (2012) Atsushi Sato et al. Stem Cells Translational Medicine
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions
- (2010) Naomi Haga et al. CANCER SCIENCE
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now